Pharmaceutical Technology

AUGUST 9, 2023

AGC has extended its Milan manufacturing facility to address the growing clinical trial and commercial demands.

Manufacturing 246

Manufacturing Clinical Trials Clinical Trials Trials 246

Pharmaceutical Technology

JUNE 27, 2023

Vertex and Lonza have entered a partnership to establish a facility in Portsmouth, US, to manufacture cell therapies for type 1 diabetes.

Manufacturing 246

Manufacturing 246

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

Pharmaceutical Technology

JUNE 7, 2023

The funding will support the new production plant and distribution hub, which is aimed at enhancing access to high-quality medicines in Africa. The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs.

Manufacturing 240

Manufacturing Drugs Production Medicine 240

Pharmaceutical Technology

MARCH 5, 2024

The UK Government announced plans to bolster the UK life science manufacturing industry through increased investment.

Life Science 130

Life Science Manufacturing 130

Pharmaceutical Technology

JANUARY 17, 2024

KBI Biopharma and Argonaut have entered into a strategic partnership to provide biopharmaceutical clients with drug manufacturing solutions.

Manufacturing 130

Manufacturing Drugs 130

Pharmaceutical Technology

MARCH 8, 2024

SK bioscience has broken ground on a significant expansion of its vaccine manufacturing facility, L HOUSE, in South Korea.

Manufacturing 130

Manufacturing Vaccination Vaccine 130

Pharma Mirror

SEPTEMBER 1, 2023

North Charleston, SC: Pharmaceutical sterilization and cleaning equipment manufacturer Belimed Life Science, North Charleston, SC, has unveiled custom wash rack design and manufacturing services.

Manufacturing 130

Manufacturing Life Science Containment Production 130

Pharmaceutical Technology

DECEMBER 19, 2023

BioNTech has inaugurated a new messenger RNA (mRNA) vaccine manufacturing facility in Kigali, Rwanda, which will have BioNTainers.

Manufacturing 130

Manufacturing Vaccination Vaccine RNA 130

Camargo

NOVEMBER 15, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA Publishes ICH Guidelines on Continuous Manufacturing. FDA Guidance Addresses Real-World Evidence Data Standards.

Development 187

Development Manufacturing Production Packaging 187

Pharmaceutical Technology

DECEMBER 27, 2023

ARTBIO is developing a proprietary radiotherapy manufacturing technology to overcome distribution and supply chain challenges.

Manufacturing 130

Manufacturing Development 130

Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Regulatory decisions and clinical trial news.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Pharmaceutical Technology

DECEMBER 15, 2023

Biovac has received an investment and advisory package from the IFC to support vaccine manufacturing and pandemic preparedness in Africa.

Manufacturing 130

Manufacturing Vaccination Vaccine Packaging 130

Pharmaceutical Technology

NOVEMBER 14, 2022

BioNTech’s Singapore affiliate BioNTech Pharmaceuticals Asia Pacific has signed an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire a GMP-certified manufacturing site in the country. . It also has the potential for extension into the manufacturing of other drug classes such as cell therapies. .

Manufacturing 162

Manufacturing Vaccination Vaccine Production 162

Pharmaceutical Technology

DECEMBER 4, 2023

GC Biopharma has concluded the construction activities at an mRNA manufacturing plant at its vaccine production site in South Korea.

Manufacturing 130

Manufacturing Vaccination Vaccine Production 130

Pharmaceutical Technology

OCTOBER 24, 2023

The award will fund the development of the company’s automated, microfluidic cell and gene therapy manufacturing platform.

Manufacturing 147

Manufacturing Gene Therapy Gene Development 147

Pharmaceutical Technology

DECEMBER 7, 2023

Synplogen and Ginkgo Bioworks have signed an MOU to expedite DNA manufacturing and gene therapy platform services in Japan.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

Pharmaceutical Technology

OCTOBER 31, 2023

The laboratory will be operational by Q3 2024, and the first manufacturing suite is expected to be operational in Q3 2025.

Manufacturing 147

Manufacturing 147

Pharmaceutical Technology

SEPTEMBER 4, 2023

Biocon Generics has purchased the US-based oral solid dosage manufacturing facility of Eywa Pharma for a total consideration of $7.7m.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 27, 2023

MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.

Manufacturing 130

Manufacturing Drugs 130

Pharmaceutical Technology

MARCH 24, 2023

Takeda has unveiled plans to invest almost $764m (JPY100bn) to construct a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. The new facility represents the company’s largest-ever investment in the expansion of manufacturing capacity in the country.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

FEBRUARY 8, 2023

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of Genenta Science.

Manufacturing 130

Manufacturing Gene Therapy Production Clinical Trials 130

Pharmaceutical Technology

AUGUST 8, 2023

Ginkgo Bioworks has entered into a new partnership with Merck (MSD) to bolster biologic manufacturing in a deal worth up to $490m.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

JANUARY 20, 2023

Increasing manufacturing capacity for pandemic prevention “The other piece we are working on is … how do we build manufacturing capacity around the world?”, The biotech has also made plans to expand manufacturing capacity elsewhere. The manufacturing expansion plans go beyond Covid-19 vaccines and therapeutics. “We

Manufacturing 246

Manufacturing Vaccination Vaccine Gene Therapy 246

Pharmaceutical Technology

MAY 2, 2023

Marker Therapeutics has reached a non-dilutive agreement to sell cell manufacturing assets to CellReady for $19m in cash. CellReady is a newly created contract development and manufacturing organisation (CDMO) founded by Marker board member and co-founder John Wilson. Both firms expect to complete the deal on 26 June 2023.

Manufacturing 130

Manufacturing Gene Therapy Gene Development 130

Pharmaceutical Technology

MARCH 13, 2023

Cytovance Biologics has entered a collaboration deal with Phenotypeca to enhance the development of saccharomyces cerevisiae strain for biopharmaceutical manufacturing. It is well suited for manufacturing certain human protein types and can also be harnessed as small, efficient factories for biopharmaceutical production.

Manufacturing 130

Manufacturing Protein Production Development 130

Pharmaceutical Technology

MAY 17, 2023

WuXi Biologics and InflaRx have entered a manufacturing partnership for advancing Gohibic (vilobelimab) to treat certain critically ill Covid-19 patients. Under the collaboration, WuXi Biologics will be responsible for providing cGMP manufacturing of Gohibic.

Manufacturing 130

Manufacturing Immune Response Protein Antibody 130

Pharmaceutical Technology

OCTOBER 17, 2023

Vaxcyte has signed a new commercial agreement with Lonza for the global manufacture of broad-spectrum PCVs.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

AUGUST 9, 2023

Teknova has opened a new modular manufacturing facility in Hollister, California, US for custom, high-quality life sciences re-agents.

Manufacturing 130

Manufacturing Life Science 130

Pharmaceutical Technology

JUNE 8, 2023

Mendus has entered an alliance with NorthX Biologics to co-establish a cell therapy manufacturing unit for its lead asset, vididencel, in Sweden. Mendus has partnered with NorthX and Swedish investment firm Flerie Invest, which will make an initial investment of Skr90m ($8.25m) in the manufacturing unit.

Manufacturing 130

Manufacturing Gene Therapy Gene Clinical Trials 130

Pharmaceutical Technology

MAY 26, 2023

Chronic disease tech company Convatec Group has partnered with Beta Bionics to manufacture the insulin delivery system iLet Bionic Pancrease. It will now be made at Convatec’s manufacturing sites in Mexico. All three pharma manufacturers of insulin – Novo Nordisk, Sanofi, and Eli Lilly – have since announced price reductions.

Insulin 147

Insulin Manufacturing Pharmacy Marketing 147

Pharmaceutical Technology

SEPTEMBER 20, 2023

The biologics manufacturing company’s CEO said robotics and AI adoption in biopharma needs to catch up to other industries.

Manufacturing 130

Manufacturing Drugs 130

Pharmaceutical Technology

JULY 28, 2023

As several economies deal with inflation, there has been a reduction in deals involving contract manufacturing organisations.

Contract Manufacturing 130

Contract Manufacturing Manufacturing 130

XTalks

JUNE 12, 2023

Bristol Myers Squibb (BMS), a multinational pharmaceutical company based in New York City, has announced that its new state-of-the-art cell therapy manufacturing facility in Devens, Massachusetts, has received approval for commercial production from the US Food and Drug Administration (FDA).

Manufacturing 95

Manufacturing Gene Therapy FDA Approval Gene 95

Pharmaceutical Technology

JANUARY 25, 2023

The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure’s AVT02 (adalimumab). Under the licence agreement for the antibody, Alvotech will be responsible for the development and manufacturing, while Bioventure will handle the marketing.

Manufacturing 147

Manufacturing Antibody Marketing Licensing 147

Pharmaceutical Technology

APRIL 25, 2023

Forge Biologics has received a qualified person (QP) declaration to manufacture adeno-associated virus (AAV) gene therapies to support European clinical programmes. The company stated that a European QP has completed an in-depth audit at its manufacturing facility in Columbus, Ohio, US.

Gene Therapy 130

Gene Therapy Gene Manufacturing Production 130

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130